SK15052000A3 - Spôsob výroby pyrazolo[4,3-d]pyrimidin-7-ón-3-pyridylsulfonylových zlúčenín a medziprodukty pre tento spôsob - Google Patents

Spôsob výroby pyrazolo[4,3-d]pyrimidin-7-ón-3-pyridylsulfonylových zlúčenín a medziprodukty pre tento spôsob Download PDF

Info

Publication number
SK15052000A3
SK15052000A3 SK1505-2000A SK15052000A SK15052000A3 SK 15052000 A3 SK15052000 A3 SK 15052000A3 SK 15052000 A SK15052000 A SK 15052000A SK 15052000 A3 SK15052000 A3 SK 15052000A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
compounds
group
reacting
Prior art date
Application number
SK1505-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Keith Michael Devries
Philip Charles Levett
Joanna Teresa Negri
Albert Shaw Wood
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9924042.6A external-priority patent/GB9924042D0/en
Priority claimed from GB0018667A external-priority patent/GB0018667D0/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of SK15052000A3 publication Critical patent/SK15052000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SK1505-2000A 1999-10-11 2000-10-09 Spôsob výroby pyrazolo[4,3-d]pyrimidin-7-ón-3-pyridylsulfonylových zlúčenín a medziprodukty pre tento spôsob SK15052000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924042.6A GB9924042D0 (en) 1999-10-11 1999-10-11 Process for thr preparation of pyrazolo[4,3-D]pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
GB0018667A GB0018667D0 (en) 2000-07-28 2000-07-28 Process for the preparation of pyrazolo [4,3-d] Pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof

Publications (1)

Publication Number Publication Date
SK15052000A3 true SK15052000A3 (sk) 2003-01-09

Family

ID=26244761

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1505-2000A SK15052000A3 (sk) 1999-10-11 2000-10-09 Spôsob výroby pyrazolo[4,3-d]pyrimidin-7-ón-3-pyridylsulfonylových zlúčenín a medziprodukty pre tento spôsob

Country Status (39)

Country Link
EP (1) EP1092720B1 (es)
JP (1) JP2001114783A (es)
KR (1) KR100395718B1 (es)
CN (1) CN1292379A (es)
AR (1) AR029767A1 (es)
AT (1) ATE286899T1 (es)
AU (1) AU6543600A (es)
BG (1) BG104840A (es)
BR (1) BR0004787A (es)
CA (1) CA2322995A1 (es)
CO (1) CO5251476A1 (es)
CZ (1) CZ20003754A3 (es)
DE (1) DE60017330D1 (es)
DZ (1) DZ3096A1 (es)
EA (1) EA003145B1 (es)
EE (1) EE200000537A (es)
EG (1) EG22775A (es)
GT (1) GT200000169A (es)
HR (1) HRP20000674A2 (es)
HU (1) HUP0003979A3 (es)
ID (1) ID27539A (es)
IL (1) IL138913A0 (es)
IN (1) IN190477B (es)
IS (1) IS5654A (es)
MA (1) MA25867A1 (es)
MX (1) MXPA00009936A (es)
NO (1) NO316072B1 (es)
NZ (1) NZ507431A (es)
OA (1) OA11495A (es)
PA (1) PA8504601A1 (es)
PE (1) PE20010682A1 (es)
PL (1) PL343140A1 (es)
SG (1) SG97950A1 (es)
SK (1) SK15052000A3 (es)
SV (1) SV2002000194A (es)
TN (1) TNSN00195A1 (es)
TR (1) TR200002959A2 (es)
UY (1) UY26388A1 (es)
YU (1) YU59100A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera
US6809200B2 (en) * 2000-07-28 2004-10-26 Pfizer Inc. Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
JP2006219373A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するピリジニルピラゾロピリミジノン誘導体
CN101309903B (zh) * 2005-11-16 2012-10-03 弗·哈夫曼-拉罗切有限公司 制备thoc的新方法
KR101002490B1 (ko) * 2007-06-09 2010-12-17 동아제약주식회사 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물
AU2012221828C1 (en) * 2011-02-23 2015-10-01 Pfizer Inc. Imidazo[5,1-f][1,2,4]triazines for treatment of neurological disorders
AU2017359604B2 (en) * 2016-11-21 2022-02-10 Adama Agan Ltd. Process for preparing methoxy methyl pyridine dicarboxylate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723719B1 (en) * 1997-04-25 2004-04-20 Pfizer Inc Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′—monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction
EP1371647B1 (en) * 1998-04-20 2005-07-13 Pfizer Inc. Pyridine-3-carboxylic acid derivatives and their use as intermediates
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
KR100353014B1 (ko) * 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera

Also Published As

Publication number Publication date
HU0003979D0 (en) 2000-12-28
HUP0003979A2 (hu) 2001-12-28
HRP20000674A2 (en) 2001-08-31
EE200000537A (et) 2001-06-15
IN190477B (es) 2003-08-02
EA003145B1 (ru) 2003-02-27
BG104840A (bg) 2001-10-31
UY26388A1 (es) 2001-05-31
EA200000924A3 (ru) 2001-06-25
IL138913A0 (en) 2001-11-25
OA11495A (en) 2004-05-05
EP1092720B1 (en) 2005-01-12
SG97950A1 (en) 2003-08-20
CA2322995A1 (en) 2001-04-11
ATE286899T1 (de) 2005-01-15
EG22775A (en) 2003-08-31
NO316072B1 (no) 2003-12-08
EP1092720A2 (en) 2001-04-18
BR0004787A (pt) 2001-05-22
KR20010050935A (ko) 2001-06-25
PA8504601A1 (es) 2002-02-21
CZ20003754A3 (cs) 2002-06-12
HUP0003979A3 (en) 2002-03-28
GT200000169A (es) 2002-04-03
EP1092720A3 (en) 2001-09-19
NO20005104D0 (no) 2000-10-10
AR029767A1 (es) 2003-07-16
AU6543600A (en) 2001-04-12
ID27539A (id) 2001-04-12
NO20005104L (no) 2001-04-17
EA200000924A2 (ru) 2001-04-23
CN1292379A (zh) 2001-04-25
YU59100A (sh) 2003-10-31
DE60017330D1 (de) 2005-02-17
TR200002959A2 (tr) 2001-07-23
DZ3096A1 (fr) 2004-06-20
IS5654A (is) 2001-04-12
KR100395718B1 (ko) 2003-08-25
PE20010682A1 (es) 2001-07-04
MA25867A1 (fr) 2003-10-01
SV2002000194A (es) 2002-01-23
PL343140A1 (en) 2001-04-23
NZ507431A (en) 2002-09-27
MXPA00009936A (es) 2002-10-23
TNSN00195A1 (fr) 2005-11-10
CO5251476A1 (es) 2003-02-28
JP2001114783A (ja) 2001-04-24

Similar Documents

Publication Publication Date Title
JP3834236B2 (ja) ピラゾロ〔４，３−ｄ〕ピリミジン誘導体
US10391099B2 (en) Method of treating psoriatic arthritis, psoriasis, and chronic obstructive pulmonary disease with a novel 2,5-substituted pyrimidines
US11286253B2 (en) Process for preparing aminopyrimidine derivatives
CA2585557C (en) Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors
SK138599A3 (en) Process for the preparation of pyrazolo[4,3-d] pyrimidin-7-ones and their intermaediates
SK15052000A3 (sk) Spôsob výroby pyrazolo[4,3-d]pyrimidin-7-ón-3-pyridylsulfonylových zlúčenín a medziprodukty pre tento spôsob
AU754962B2 (en) Process for the preparation of pyrazolo(4,3-d)pyrimidin-7- one compounds and intermediates thereof
FI82456B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-fenyl-1,2,4-tiadiazin-1-oxidderivat.
US6809200B2 (en) Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
MXPA99009326A (es) Procedimiento para la preparacion de pirazolo [4,3-d]pirimidin-7-onas y sus intermedios
CZ20003882A3 (cs) Pyrazolpyrimidinové inhibitory CGMP PDE5 pro léčbu sexuálních dysfunkcí